IRF3 and neoplasm: After IR, mitochondrial DNA is oxidized in tumor cells, which will be phagocytosed by DCs and activate the STING-TBK1-IRF3-IFN-β pathway in DCs, which subsequently cross-presented irradiated tumor cell-derived antigens to CD8+T cells and elicited antitumor immunity (37).